AdvaMed

Rule Changes

Supporting pathway, lobbying for broader coverage

For nearly a decade, medical device makers have faced the same bottleneck: the FDA clears a breakthrough device, and then Medicare spends another year or more deciding whether to pay for it. On April 23, the two agencies announced a joint pathway to collapse that gap to as little as two months.

Updated 3 hours ago